Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Neoadjuvant Therapy × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 8 Neoplasms 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Lung Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Microsatellite Instability 1 Melanoma 1 Medulloblastoma 1 Liposarcoma 1 Leiomyosarcoma 1 Intermittent Fasting 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Magnetic Resonance Spectroscopy 5 Biopsy 4 X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 Radiotherapy 2 Nivolumab 2 Lomustine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 regorafenib 1 perillyl alcohol 1 pemigatinib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡